Taking The Temperature Of Accelerated Approval: An Interview With Ariad's President Of R&D Tim Clackson (Part 1 Of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
R&D head talks about the company's lead candidate ponatinib's developmental plan under accelerated approval.